Skip Navigation

Christopher Sweeney, MBBS


Medical Oncology

Make an Appointment
Watch Video

Physician

  • Institute Physician
  • Professor of Medicine, Harvard Medical School

Centers/Programs

Clinical Interests

  • Bladder cancer
  • Clinical trials
  • Hormone and chemotherapy
  • Kidney cancer
  • Prostate cancer
  • Testicular cancer

Contact Information

  • Appointments877-332-4294 (new)
    617-582-9725 (follow-up)
  • Office Phone Number617-632-1914
  • Fax617-632-2165

Board Certification:

  • Internal Medicine, 1997
  • Medical Oncology, 2000

Fellowship:

  • Indiana University, Hematology and Oncology

Residency:

  • Gundersen Lutheran Medical Center, Internal Medicine

Medical School:

  • University of Adelaide, Australia

Recent Awards:

  • Membership of the American Society of Clinical Oncology, Eastern Cooperative Oncology Group, and American Association for Cancer Research.
  • Chairman of the Hoosier Oncology Group 2005-2007
  • Program Committee and the Cancer Education Committee of the American Society of Clinical Oncology
  • Editorial Board, Journal of Clinical Oncology
  • Peer-reviewed funding from the National Institutes of Health and the Department of Defense, Lance Armstrong Foundation, and PhRMA.

Research

Preclinical drug development and drug evaluation, clinical trials in genitourinary malignancies (prostate, bladder, kidney, and testis cancer)

Dr. Sweeney has focused his academic career on the management of genitourinary malignancies, including prostate, bladder, testis, and renal cell cancer. His research interest has been primarily focused on drug development. This has included (i) design and conduct of phase I trials of new agents or new combinations that assess the safety and distribution of the drug in the body as well as the anti-cancer activity of the therapy; (ii) assessment of genetic variants and blood markers to try and define signatures that identify patients who are destined to benefit from a therapy; (iii) design and conduct of phase 2 and 3 clinical trials with a focus on bladder and prostate cancer and (iv) drug discovery and evaluation in the laboratory to guide clinical trial design.

Location

Dana-Farber Cancer Institute
450 Brookline Avenue
Boston, MA 02215
Get Directions

Top